Evidence map›Paper›PMID 29272106›Full record

ReviewAccounts of chemical research2018

Electronic and Steric Tuning of a Prototypical Piano Stool Complex: Rh(III) Catalysis for C-H Functionalization.

Tiffany Piou, Tomislav Rovis

Abstract readReview
In one paragraph

Review in Accounts of chemical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Stable Two-Legged Parent Piano-Stool and Mixed Diborabenzene-EAngewandte Chemie (International ed. in English) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mechanochemical Solvent-Free Catalytic C-H Methylation.Angewandte Chemie (International ed. in English) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tiffany PiouDepartment of Chemistry, Columbia University , New York, New York 10027, United States.
Tomislav RovisDepartment of Chemistry, Columbia University , New York, New York 10027, United States.ORCID 0000-0001-6287-8669

Funding

Asymmetric Synthesis of Nitrogen HeterocyclesR01GM080442 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ROVIS, TOMISLAV · 2007 to 2024
$5.5M
NIGMS NIH HHS R01 GM080442
6 · The paper itself

Abstract

The history of transition metal catalysis is heavily steeped in ligand design, clearly demonstrating the importance of this approach. The intimate relationship between metal and ligand can profoundly affect the outcome of a reaction, often impacting selectivity, physical properties, and the lifetime of a catalyst. Importantly, this metal-ligand relationship can provide near limitless opportunities for reaction discovery. Over the past several years, transition-metal-catalyzed C-H bond functionalization reactions have been established as a critical foundation in organic chemistry that provides new bond forming strategies. Among the d-block elements, palladium is arguably one of the most popular metals to accomplish such transformations. One possible explanation for this achievement could be the broad set of phosphine and amine based ligands available in the chemist's toolbox compatible with palladium. In parallel, other metals have been investigated for C-H bond functionalization. Among them, pentamethylcyclopentadienyl (Cp*) Rh(III) complexes have emerged as a powerful mode of catalysis for such transformations providing a broad spectrum of reactivity. This approach possesses the advantage of often very low catalyst loading, and reactions are typically performed under mild conditions allowing broad functional group tolerance. Cp*Rh(III) is considered as a privileged catalyst and a plethora of reactions involving a C-H bond cleavage event have been developed. The search for alternative cyclopentadienyl based ligands has been eclipsed by the tremendous effort devoted to exploring the considerable scope of reactions catalyzed by Cp*Rh(III) complexes, despite the potential of this strategy for enabling reactivity. Thus, ligand modification efforts in Rh(III) catalysis have been an exception and research directed toward new rhodium catalysts has been sparse. Recently, chiral cyclopentadienyl ligands have appeared allowing enantioselective Rh(III)-catalyzed C-H functionalization reactions to be performed. Alongside chiral ligands, an equally important collection of achiral cyclopentadienyl-derived ligands have also emerged. The design of this new set of ligands for rhodium has already translated to significant success in solving inherent problems of reactivity and selectivity encountered throughout the development of new Rh(III)-catalyzed transformations. This Account describes the evolution of cyclopentadienyl ligand skeletons in Rh(III)-catalysis since the introduction of pentamethylcyclopentadienyl ligands to the present. Specific emphasis is placed on reactivity and synthetic applications achieved with the new ligands with the introduction of achiral mono-, di-, or pentasubstituted cyclopentadienyl ligands exhibiting a stunning effect on reactivity and selectivity. Furthermore, an underlying question when dealing with ligand modification strategies is to explain the reason one ligand outperforms another. Conjecture and speculation abound, but extensive characterization of their steric and electronic properties has been carried out and information about electronic and steric properties of the ligands all contribute to our understanding and give crucial pieces to solve the puzzle.

Indexed as

CatalysisLigandsMolecular StructureOrganometallic CompoundsPyridonesQuinolonesRhodiumStereoisomerismLigandsOrganometallic CompoundsPyridonesQuinolonesRhodium

Identifiers

PMID29272106
PMCPMC5850939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.